Comphya
Comphya developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs.
Total raised
€9.9M
€9,924,116
Funding rounds
3
Investors
2
distinct backers
Active since
2020-12
latest 2025-07
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood59
base rate 44% for Series A
- ▲ In typical raise window
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 9y since founding
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-07-08 | Series A | €8.0M | — | View deal → |
| 2023-01-31 | Debt | €851k | Existing investors,Praxis Spinal Cord Institute | View deal → |
| 2020-12-02 | Seed | €1.1M | — | View deal → |
Related news
- Comphya raises funds for clinical trialsstartupticker.ch · 2023-01
- eu-startups.com
- startupticker.ch
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy